ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 53 filers reported holding ENZON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $14,000 | -80.3% | 28,947 | -72.4% | 0.00% | – |
| Q4 2015 | $71,000 | -25.3% | 104,736 | +7.1% | 0.00% | – |
| Q3 2015 | $95,000 | -48.4% | 97,836 | -36.1% | 0.00% | – |
| Q2 2015 | $184,000 | +10.2% | 153,222 | -2.6% | 0.00% | – |
| Q1 2015 | $167,000 | -29.5% | 157,256 | -27.6% | 0.00% | – |
| Q4 2014 | $237,000 | -41.2% | 217,094 | -41.7% | 0.00% | – |
| Q3 2014 | $403,000 | -10.4% | 372,368 | -14.1% | 0.00% | – |
| Q2 2014 | $450,000 | -2.0% | 433,520 | -2.6% | 0.00% | – |
| Q1 2014 | $459,000 | -20.7% | 445,186 | -10.8% | 0.00% | – |
| Q4 2013 | $579,000 | +5.9% | 499,249 | +53.4% | 0.00% | – |
| Q3 2013 | $547,000 | -11.8% | 325,533 | +4.9% | 0.00% | – |
| Q2 2013 | $620,000 | -21.5% | 310,236 | +73.9% | 0.00% | – |
| Q4 2012 | $790,000 | -37.0% | 178,414 | -1.0% | 0.00% | -100.0% |
| Q3 2012 | $1,254,000 | +0.1% | 180,165 | -1.2% | 0.00% | 0.0% |
| Q2 2012 | $1,253,000 | +56.6% | 182,383 | +56.1% | 0.00% | – |
| Q1 2012 | $800,000 | – | 116,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|